Signature Biogenetics India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-01-2025
- Paid Up Capital ₹ 0.40 M
as on 02-01-2025
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -14.64%
(FY 2020)
- Profit 441.03%
(FY 2020)
- Ebitda -764.11%
(FY 2020)
- Net Worth 8.30%
(FY 2020)
- Total Assets 4.58%
(FY 2020)
About Signature Biogenetics India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Hari Thakur and Ugra Thakur serve as directors at the Company.
- CIN/LLPIN
U74900BR2012PTC019130
- Company No.
019130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2012
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Signature Biogenetics India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Thakur  | Managing Director | 24-Aug-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ugra Thakur | Director | 24-Aug-2012 | Current |
Financial Performance of Signature Biogenetics India.
Signature Biogenetics India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.64% decrease. The company also saw a substantial improvement in profitability, with a 441.03% increase in profit. The company's net worth moved up by a moderate rise of 8.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Signature Biogenetics India?
In 2017, Signature Biogenetics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
International Signature Chemical & Fertilizers Private LimitedActive 6 years 8 monthsHari Thakur and Ugra Thakur are mutual person
- Goldmedal Sweta Bio Genetics India Private LimitedActive 8 years 2 months
Ugra Thakur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Signature Biogenetics India?
Unlock and access historical data on people associated with Signature Biogenetics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Signature Biogenetics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Signature Biogenetics India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
